Theravance Biopharma Inc (NAS:TBPH)
$ 9.85 0.46 (4.9%) Market Cap: 479.04 Mil Enterprise Value: 399.84 Mil PE Ratio: 0 PB Ratio: 2.33 GF Score: 47/100

Theravance Biopharma Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript

May 13, 2021 / 06:45PM GMT
Release Date Price: $18.72 (-0.79%)
Tazeen Ahmad
BofA Securities, Research Division - VP

Good afternoon, everybody. Thanks so much for joining us at the Bank of America Healthcare Conference. It's my pleasure to have our next presenting company with me Theravance Biopharma. I have a long history with Theravance. You guys are one of the longest-running coverage companies that I've had going back over a decade, I think. So Rick, it's good to see you always. Rick Winningham, of course, CEO of Theravance Biopharma.

Rick E. Winningham
Theravance Biopharma, Inc. - Chairman & CEO

Great to see you, Tazeen, and thanks so much for the invitation.

Tazeen Ahmad
BofA Securities, Research Division - VP

Rick, you have a couple of colleagues with you on this call. I'll let you introduce them.

Rick E. Winningham
Theravance Biopharma, Inc. - Chairman & CEO

Sure. Joining me today are Andrew Hindman, our CFO; and Rick Graham, who's our Senior Vice President of Development and is responsible for the development

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot